Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma

BACKGROUND: Oral cavity squamous cell carcinoma (OSCC) is an aggressive malignant tumor with high recurrence and poor prognosis in the advanced stage. Patient-derived xenografts (PDXs) serve as powerful preclinical platforms for drug testing and precision medicine for cancer therapy. We assess which...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Wei-Chen, Chang, Ian Yi-Feng, Chang, Kai‐Ping, Ouyang, Chun‐Nan, Liu, Chiao-Rou, Tsai, Ting-Lin, Zhang, Yi-Cheng, Wang, Chun-I, Wang, Ya-Hui, Yu, Alice L., Liu, Hsuan, Wu, Chih-Ching, Chang, Yu-Sun, Yu, Jau-Song, Yang, Chia-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013835/
https://www.ncbi.nlm.nih.gov/pubmed/35444950
http://dx.doi.org/10.3389/fonc.2022.792297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013835/
https://www.ncbi.nlm.nih.gov/pubmed/35444950
http://dx.doi.org/10.3389/fonc.2022.792297

Ejemplares similares